Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (711-720 of 1,095) with videos related to

Pageof 110
Sort By:
BJU International|February 28, 2012
Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian surveyCristina Masini, Roberto Sabbatini, Camillo Porta, et al.
Journal of Hepatology|April 16, 2019
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacyCihan Yurdaydin, Zaigham Abbas, Maria Buti, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
READY: REAl-world Data from an Italian compassionate use program of avelumab first-line maintenance for locallY advanced or metastatic urothelial carcinomaL Antonuzzo, M Maruzzo, U De Giorgi, et al.
Annals of Hepatology|June 14, 2014
PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis CJavier Ampuero, José A Del Campo, Lourdes Rojas, et al.
Medicina Clinica|November 9, 2007
[Adefovir dipivoxil compassionate use program in Spain: efficacy and resistance analysis]María Buti, Francisco Rodríguez Frías, José Luis Calleja, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|February 15, 2013
[Promoting the quality of health surveillance of workers exposed to wood dust, with particular care to NPSC, in the territory of the Health Agency of Florence]L A Pristerà, C Sgarrella, F Luongo, et al.
Clinical and Experimental Gastroenterology|December 7, 2016
HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infectionChristoph Sarrazin, Francesco Castelli, Pietro Andreone, et al.
JHEP Reports : Innovation in Hepatology|March 13, 2023
Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cellsAbhishek Aggarwal, Pamela M Odorizzi, Jens Brodbeck, et al.
Future Oncology (London, England)|March 12, 2015
Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patientsOrazio Caffo, Giovanni Lo Re, Teodoro Sava, et al.
Therapeutic Advances in Medical Oncology|March 3, 2022
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinibSara Elena Rebuzzi, Luigi Cerbone, Alessio Signori, et al.
Pageof 110

Showing results (711-720 of 1,095) with videos related to

Sort By:
Pageof 110
BJU International|February 28, 2012
Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian surveyCristina Masini, Roberto Sabbatini, Camillo Porta, et al.
Journal of Hepatology|April 16, 2019
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacyCihan Yurdaydin, Zaigham Abbas, Maria Buti, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
READY: REAl-world Data from an Italian compassionate use program of avelumab first-line maintenance for locallY advanced or metastatic urothelial carcinomaL Antonuzzo, M Maruzzo, U De Giorgi, et al.
Annals of Hepatology|June 14, 2014
PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis CJavier Ampuero, José A Del Campo, Lourdes Rojas, et al.
Medicina Clinica|November 9, 2007
[Adefovir dipivoxil compassionate use program in Spain: efficacy and resistance analysis]María Buti, Francisco Rodríguez Frías, José Luis Calleja, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|February 15, 2013
[Promoting the quality of health surveillance of workers exposed to wood dust, with particular care to NPSC, in the territory of the Health Agency of Florence]L A Pristerà, C Sgarrella, F Luongo, et al.
Clinical and Experimental Gastroenterology|December 7, 2016
HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infectionChristoph Sarrazin, Francesco Castelli, Pietro Andreone, et al.
JHEP Reports : Innovation in Hepatology|March 13, 2023
Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cellsAbhishek Aggarwal, Pamela M Odorizzi, Jens Brodbeck, et al.
Future Oncology (London, England)|March 12, 2015
Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patientsOrazio Caffo, Giovanni Lo Re, Teodoro Sava, et al.
Therapeutic Advances in Medical Oncology|March 3, 2022
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinibSara Elena Rebuzzi, Luigi Cerbone, Alessio Signori, et al.
Pageof 110